<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2023.1271919</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Etiologic characteristics revealed by mNGS-mediated ultra-early and early microbiological identification in airway secretions from lung transplant recipients</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Xiaoqin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1950823"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tang</surname>
<given-names>Xuemei</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2296378"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yi</surname>
<given-names>Xiaoli</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lei</surname>
<given-names>Yu</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lu</surname>
<given-names>Sen</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Tianlong</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1978167"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yue</surname>
<given-names>Ruiming</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1282206"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pan</surname>
<given-names>Lingai</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1835294"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Feng</surname>
<given-names>Gang</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1943288"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Huang</surname>
<given-names>Xiaobo</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wang</surname>
<given-names>Yiping</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Cheng</surname>
<given-names>Deyun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2179167"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Respiratory and Critical Care Medicine, West China Hospital, West China Clinical Medical School, Sichuan University</institution>, <addr-line>Chengdu</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Critical Care Medicine, Sichuan Provincial People&#x2019;s Hospital, University of Electronic Science and Technology of China</institution>, <addr-line>Chengdu</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Medical Department, Genoxor Medical Science and Technology Inc.</institution>, <addr-line>Shanghai</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Thoracic Surgery, Sichuan Provincial People&#x2019;s Hospital, University of Electronic Science and Technology of China</institution>, <addr-line>Chengdu</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Hua Zhong, University of Hawaii at Manoa, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Peng Cao, Huazhong University of Science and Technology, China; Si-Yuan Song, Baylor College of Medicine, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Deyun Cheng, <email xlink:href="mailto:cdy1963@qq.com">cdy1963@qq.com</email>; Yiping Wang, <email xlink:href="mailto:wangyiping@uestc.edu.cn">wangyiping@uestc.edu.cn</email>; Xiaobo Huang, <email xlink:href="mailto:drhuangxb@163.com">drhuangxb@163.com</email>; Gang Feng, <email xlink:href="mailto:steedvan@163.com">steedvan@163.com</email>
</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work and share first authorship</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>21</day>
<month>09</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1271919</elocation-id>
<history>
<date date-type="received">
<day>03</day>
<month>08</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>04</day>
<month>09</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Zhang, Tang, Yi, Lei, Lu, Li, Yue, Pan, Feng, Huang, Wang and Cheng</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Zhang, Tang, Yi, Lei, Lu, Li, Yue, Pan, Feng, Huang, Wang and Cheng</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Post-operative etiological studies are critical for infection prevention in lung transplant recipients within the first year. In this study, mNGS combined with microbial culture was applied to reveal the etiological characteristics within one week (ultra-early) and one month (early) in lung transplant recipients, and the epidemiology of infection occurred within one month.</p>
</sec>
<sec>
<title>Methods</title>
<p>In 38 lung transplant recipients, deep airway secretions were collected through bronchofiberscope within two hours after the operation and were subjected to microbial identification by mNGS and microbial culture. The etiologic characteristics of lung transplant recipients were explored. Within one month, the infection status of recipients was monitored. The microbial species detected by mNGS were compared with the etiological agents causing infection within one month.</p>
</sec>
<sec>
<title>Results</title>
<p>The detection rate of mNGS in the 38 airway secretions specimens was significantly higher than that of the microbial culture (P&lt;0.0001). MNGS identified 143 kinds of pathogenic microorganisms; bacterial pathogens account for more than half (72.73%), with gram-positive and -negative bacteria occupying large proportions. Fungi such as <italic>Candida</italic> are also frequently detected. 5 (50%) microbial species identified by microbial culture had multiple drug resistance (MDR). Within one month, 26 (68.42%) recipients got infected (with a median time of 9 days), among which 10 (38.46%) cases were infected within one week. In the infected recipients, causative agents were detected in advance by mNGS in 9 (34.62%) cases, and most of them (6, 66.67%) were infected within one week (ultra-early). In the infection that occurred after one week, the consistency between mNGS results and the etiological agents was decreased.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>Based on the mNGS-reported pathogens in airway secretions samples collected within two hours, the initial empirical anti-infection regimes covering the bacteria and fungi are reasonable. The existence of bacteria with MDR forecasts the high risk of infection within 48 hours after transplant, reminding us of the necessity to adjust the antimicrobial strategy. The predictive role of mNGS performed within two hours in etiological agents is time-limited, suggesting continuous pathogenic identification is needed after lung transplant.</p>
</sec>
</abstract>
<kwd-group>
<kwd>lung transplant</kwd>
<kwd>mNGS</kwd>
<kwd>airway secretions</kwd>
<kwd>early infection</kwd>
<kwd>etiology</kwd>
</kwd-group>
<counts>
<fig-count count="3"/>
<table-count count="4"/>
<equation-count count="0"/>
<ref-count count="47"/>
<page-count count="11"/>
<word-count count="4521"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Alloimmunity and Transplantation</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Although the first human lung transplant was performed in 1963, the operation became a clinical reality for treating end-stage lung diseases until the mid-1980s, after overcoming most surgical and pharmacologic challenges (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). Nevertheless, the morbidity and mortality remain high, and the survival rate in lung transplant recipients is lower than of other solid organ transplant recipients, with a 5-year survival rate of 55.6% (<xref ref-type="bibr" rid="B3">3</xref>). Rejection- and infection-related complications are the main factors for overall morbidity and mortality in lung transplant recipients (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>). For lung transplant recipients, infection is a significant complication. It represents the most common cause of death within the first year, and pulmonary infection-related respiratory failure is the leading cause of death during post-operative admission (&lt;30 days) (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). So far, most of the post-operative etiological studies in lung transplants mainly focus on the episodes of infection that occurred within three months or one year following the operation. In a previous epidemiological study in which 51 lung transplant recipients were followed for a mean of 38.2 months, 42% of infectious episodes occurred within the first three months, and 75% developed within the first year after transplant (<xref ref-type="bibr" rid="B8">8</xref>). However, infections that occur within one week (ultra-early) and one month (early) after transplantation are rarely paid attention to, and the associated etiological study is insufficient.</p>
<p>Traditional etiological diagnosis methods of bronchoscopy specimens include airway secretions for microbial culture, smear microscopy, and histopathology (<xref ref-type="bibr" rid="B9">9</xref>). In lung transplant recipients, airway secretions microbial culture is the most frequently adopted for etiological examination to diagnose pulmonary infection (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>). However, the positive rate of microbial culture is low because of the limitation in microbial cultivating techniques and the impact of lesions surrounded by fibrous tissue and antibiotic application history (<xref ref-type="bibr" rid="B9">9</xref>). Consequently, molecular diagnostic technologies are emerging as complementary methodologies for pathogenic detection (<xref ref-type="bibr" rid="B12">12</xref>), including the polymerase chain reaction that focuses on a specific pathogen (<xref ref-type="bibr" rid="B13">13</xref>).</p>
<p>Metagenomic next-generation sequencing (mNGS), an unbiased and practical approach for pathogen identification with a shorter turn-around time, has been employed to diagnose infectious diseases (<xref ref-type="bibr" rid="B14">14</xref>). In liver transplant recipients, mNGS was adopted in the diagnosis and treatment guidance of post-operative infection, showing distinct advantages in detecting mixed, viral, and parasitic infections over the traditional culture method (<xref ref-type="bibr" rid="B15">15</xref>). Compared with urine culture, mNGS performed more remarkably in etiological diagnosis for kidney transplant recipients with urinary tract infections (<xref ref-type="bibr" rid="B16">16</xref>). In lung transplant recipients, mNGS is committed to pathogenic detection in airway secretions samples, with a shorter turn-around time, providing timely information for diagnosing pulmonary infections (<xref ref-type="bibr" rid="B17">17</xref>). These findings highlight the great potential of mNGS in detecting pathogenic microorganisms and identifying infection in lung transplant recipients. Herein, the secretions samples were absorbed through a bronchofiberscope from the deep airway within two hours after lung transplant. Airway secretions were subjected to mNGS test and microbial culture to reveal the ultra-early microbial characteristics and analyze the pulmonary infection within one month in recipients. Our data may offer a critical reference for antimicrobial regimens to prevent infections developed within one week or month, thereby reducing the related mortality.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="s2_1">
<title>Lung transplant recipient enrollment</title>
<p>Patients undergoing lung transplantation at Sichuan Provincial People&#x2019;s Hospital from October 2018 to June 2022 were included in this study. The inclusive and exclusive criteria for donor lungs were described in our previous study (<xref ref-type="bibr" rid="B18">18</xref>), and listed as follows.</p>
<p>Donor lungs inclusion criteria: (a) Age &lt; 60 years old, smoking history &lt; 20 packs/year. (b) No chest injury. (c) Continuous mechanical ventilation &lt; 1 week. (d) PaO<sub>2</sub> &gt; 300 mmHg (FiO<sub>2</sub>&#xa0;=&#xa0;100%, PEEP = 5cm H<sub>2</sub>O). (e) X-ray or CT shows that the lung field is relatively clear. (f) No abscess secretion was found through bronchoscopy in the lung bronchus.</p>
<p>Donor lungs exclusion criteria: (a) Age &gt; 60 years old, smoking history &gt; 20 packs/year. (b) Chest trauma and lung contusion. (c) Continuous mechanical ventilation &gt; 1 week. (d) PaO<sub>2</sub> &lt; 300 mmHg (FiO<sub>2</sub>&#xa0;=&#xa0;100%, PEEP = 5cm H<sub>2</sub>O). (e) X-ray or CT shows that the lung field is infected. (f) There are purulent secretions at bronchoscopy in the donor&#x2019;s lower airways. (g) The percentage of white blood cells, neutrophils, C-reactive protein, and procalcitonin increases gradually compared with the situation at the onset of the disease. (h) The donor&#x2019;s body temperature is higher than normal. (i) Blood culture is positive.</p>
</sec>
<sec id="s2_2">
<title>Study design and sample collection</title>
<p>Basic information about the enrolled recipients, including age, sex, primary indications for a lung transplant, types of lung transplantation (bilateral or unilateral), and infection status within one month following the operation, was recorded. Prognostic information on the enrolled patients&#x2019; antimicrobial use, mechanical ventilation, and ICU hospitalization was recorded in detail.</p>
<p>In most lung transplant centers in China, timely bronchofiberscopy after surgery is a routine examination aiming to clean the airway secretions through a bronchofiberscope, which helps to avoid obstructing the small airway and reduce pathogens. Therefore, airway secretions were absorbed from the deep airway by bronchofiberscope two hours after the operation and sent for traditional microbial culture and mNGS for pathogen detection immediately. In the following days, within one month, airway secretions or BALFs were collected for microbial culture every few days, depending on the actual conditions in recipients. Microbial culture for the above samples was conducted in our hospital. The yielded pathogen spectrum was analyzed and compared between these two methods. The incidence of infection within one month and the occurrence time in these recipients were determined. The causative agents for infection were compared with the pathogenic microorganisms reported by mNGS in airway secretions collected within two hours to evaluate the role of mNGS in forewarning potential pathogens.</p>
</sec>
<sec id="s2_3">
<title>mNGS procedure</title>
<p>The whole process of mNGS was completed by Genoxor Medical Science and Technology Inc. (Shanghai, China). The airway secretions samples were stored at 4&#xb0;C and sent for mNGS detection within 24h. These steps included pre-treatment, DNA extraction, library construction, sequencing, bioinformatic analysis, and interpretation of data (<xref ref-type="bibr" rid="B19">19</xref>). A 1.5ml microcentrifuge tube containing 0.6ml of sample, enzyme, and 1.0g of glass beads (0.5mm) was attached to a horizontal platform on a vortex mixer and agitated vigorously at 2,800&#x2013;3,200 rpm for 30&#xa0;min. Then DNA in airway secretions samples was extracted using the TIANamp Micro DNA Kit (DP316, Tiangen Biotech) according to the manufacturer&#x2019;s instructions. After DNA concentration and purity detection, the libraries were constructed undergoing DNA fragmentation, end-repair, adapter ligation, and PCR amplification. DNA library concentration was measured by Qubit 2.0. An Agilent 2100 test achieved quality control of the DNA libraries. After being pre-quantified by qRT-PCR, quality-qualified libraries were sequenced on the NextSeq&#x2122; 550DX platform in SE-75 sequencing type according to the manufacturer&#x2019;s instructions.</p>
</sec>
<sec id="s2_4">
<title>Data analysis and quality control</title>
<p>Bioinformatics analysis of the mNGS data was performed according to the procedure described in a previous study (<xref ref-type="bibr" rid="B20">20</xref>). Raw data (raw reads) were subjected to a quality control process for trimming adapter sequences and removing low-quality tails, reads, and connector sequences using Trimmomatic v0.36 (<xref ref-type="bibr" rid="B21">21</xref>). The obtained high-quality and adequate data are called clean reads. Reads mapping to the human genome GRCh37 were removed using the calibration software Bowtie v2.2.6 (<xref ref-type="bibr" rid="B22">22</xref>), and the remaining were called unmapped reads (microbial reads). All the microbial reads were deposited in the database under the Sequence Read Archive (SRA) accession number PRJNA932550. Unmapped% refers to the proportion of microbial reads in the clean reads. Duplicated reads introduced in the PCR step were deleted using FASTX-Toolkit, Fulcrum, FastUniq, and CD-HIT-DUP tools (<xref ref-type="bibr" rid="B23">23</xref>). Subsequently, Kraken v2.0.9-beta (<xref ref-type="bibr" rid="B24">24</xref>) was adopted for the taxonomic classification of microbial reads, with a microbial genome database in NCBI constructed using 51543 genomes of about 27000 species (<ext-link ext-link-type="uri" xlink:href="ftp://ftp.ncbi.nlm.nih.gov/genomes/">ftp://ftp.ncbi.nlm.nih.gov/genomes/</ext-link>) (<xref ref-type="bibr" rid="B25">25</xref>). The number of reads in the Kraken classification report was further estimated by the Bayesian algorithm named Bracken to produce species-level abundance estimates (<xref ref-type="bibr" rid="B26">26</xref>). The estimates of the percentage relative abundance of each species were computed using the reads per kilobase of transcript per million mapped reads (RPKM), a normalization method for mNGS reads, and RPKM was calculated using the formula: gene reads/[the total mapped reads (millions) &#xd7; genome length (KB)] (<xref ref-type="bibr" rid="B27">27</xref>).</p>
</sec>
<sec id="s2_5">
<title>Criteria for defining positive results of mNGS</title>
<p>The mNGS assay was employed for detecting microorganisms, including bacteria, viruses, fungi, and parasites, and a positive result will be judged if it satisfies any of the following criteria described previously (<xref ref-type="bibr" rid="B17">17</xref>). 1) The relative abundance of bacteria (excluding <italic>M. tuberculosis</italic> complex) and fungi was greater than 30% at the genera level; 2) Virus detection was considered when the stringent map read number (SMRN) was &#x2265;3. 3) For <italic>M. tuberculosis</italic> complex, at least one number of reads should be aligned to the reference genome at the species or the genus level. However, a positive mNGS finding did not invariably indicate the presence of causative pathogens. Microorganisms detected with mNGS were categorized into colonized, putative, and pathogenic microorganisms. It would be the clinician&#x2019;s responsibility to determine the putative pathogens and pathogenic microorganisms through comprehensive clinical assessments. In the pathogenic spectrum analysis, the proportion of the pathogenic species, the detection frequency, was calculated with a formulation: the number of samples in which a particular species was detected/the total number of samples.</p>
</sec>
<sec id="s2_6">
<title>Diagnosis of infection and judgment of pathogenic agents</title>
<p>Before and after the lung transplant, the infectious risk and status of the recipients were monitored. The suspicion and diagnosis of infection were based on several clinical symptoms, including body temperature, computed tomography, etiological examination, and immune indicators. In the infected recipients, the putative pathogens and pathogenic microorganisms were judged based on a comprehensive analysis of clinical data, including the number of reads for mNGS, the clinical presentations, radiologic manifestations, conventional detection findings, clinical epidemiology, and the treatment effect of the antibiotic therapy. The putative pathogens or pathogenic microorganisms could be ascertained if the two clinicians approved. Further discussion by senior clinicians is needed in case of a significant disagreement between the first two clinicians. Then, the targeted antibiotic therapy was formulated to fight against infection, and a favorable outcome further confirmed the causative agent. The consistency of mNGS with the causative agents in the infected recipients was evaluated at the species level.</p>
</sec>
<sec id="s2_7">
<title>Statistical analysis</title>
<p>Descriptive statistics were computed for the overall samples and stratified by the positive pathogen detected by mNGS on airway secretions samples. Mean &#xb1; standard deviation (SD) or median (interquartile range, IQR) was used for describing the continuous variables. Chi-squared or Fisher&#x2019;s Exact test was used to compare the two groups&#x2019; differences. The significance level was set at 0.05. All statistical analyses were performed using the GraphPad software 8.0.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>General information of study participants</title>
<p>From October 2018 to June 2022, 40 patients received lung transplant surgery in our hospital, and 38 eligible patients were included for the final analysis. Two recipients were excluded because of death quickly without any microbial culture result. Basic information of these patients was provided in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1</bold>
</xref>. Of all 38 lung transplant recipients, the mean age was 58.13 years (ranges 33-70), including 33 (86.84%) males. The most common primary disease was COPD (19, 50%), followed by interstitial lung disease (18, 47.37%), with the addition of one patient with pneumosilicosis. In terms of the lung transplant types, 23 (60.53%) underwent bilateral transplantation and 15 (39.47%) unilateral transplantation. In the 38 recipients, new-onset infection within one month occurred in 26 (68.42%). These clinical characteristics were recorded and demonstrated in <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>. After lung transplant, the initial antibiotic regimens frequently include Sulbactam/Cefopcrazone and Piperacillin Sodium/Tazobactam Sodium. Immunosuppressant regiments comprise cyclosporin A, tacrolimus, and methylprednisolone.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Characteristics of the lung transplant recipients.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Characteristics</th>
<th valign="top" align="left">Values</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Lung transplant recipients (n)</td>
<td valign="top" align="left">38</td>
</tr>
<tr>
<td valign="top" align="left">Median age, y (IQR)</td>
<td valign="top" align="left">60.5 (52.8-65.3)</td>
</tr>
<tr>
<td valign="top" align="left">Sex (male, %)</td>
<td valign="top" align="left">33 (86.84%)</td>
</tr>
<tr>
<th valign="top" colspan="2" align="left">Primary indications for lung transplantation, n (%)</th>
</tr>
<tr>
<td valign="top" align="left">COPD</td>
<td valign="top" align="left">19 (50%)</td>
</tr>
<tr>
<td valign="top" align="left">Interstitial lung disease</td>
<td valign="top" align="left">18 (47.37%)</td>
</tr>
<tr>
<td valign="top" align="left">Pneumosilicosis</td>
<td valign="top" align="left">1 (2.63%)</td>
</tr>
<tr>
<th valign="top" colspan="2" align="left">Types of lung transplantation, n (%)</th>
</tr>
<tr>
<td valign="top" align="left">Bilateral lung transplantation</td>
<td valign="top" align="left">23 (60.53%)</td>
</tr>
<tr>
<td valign="top" align="left">Unilateral lung transplantation</td>
<td valign="top" align="left">15 (39.47%)</td>
</tr>
<tr>
<th valign="top" colspan="2" align="left">Infection status within one month, n (%)</th>
</tr>
<tr>
<td valign="top" align="left">Infected</td>
<td valign="top" align="left">26 (68.42%)</td>
</tr>
<tr>
<td valign="top" align="left">Uninfected</td>
<td valign="top" align="left">12 (31.58%)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>COPD, chronic obstructive pulmonary disease.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_2">
<title>Pathogenic spectrum generated by mNGS and traditional microbial culture</title>
<p>38 airway secretions samples from 38 lung transplant recipients were collected within two hours after surgery and simultaneously sent for etiological examination by traditional microbial culture and mNGS. The study design is illustrated in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>. The detecting results of the two methods in each patient were provided in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1</bold>
</xref>. This <xref ref-type="supplementary-material" rid="SM1">
<bold>supplementary material</bold>
</xref> also included detailed information concerning each sample&#x2019;s sequencing number of reads (raw reads, clean reads, clean reads/raw reads, unmapped reads, and unmapped %), as well as the putative pathogens in each patient and their relative abundance. It demonstrates that the raw reads range from 4M to 57M, with an average of 20M; most ratios of clean reads to raw reads are above 90%. Unmapped% refers to the proportion of microbial reads in the clean reads, ranging from 0.69% to 79.21%.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>The flowchart of the study design.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1271919-g001.tif"/>
</fig>
<p>143 kinds of pathogenic microorganisms were found in 35 (92.11%, 35/38) airway secretions specimens using mNGS, while the detection rate by microbial culture was 26.31% (10/38) (P&lt;0.0001) (<xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>). Statistically, mNGS identified pathogenic microorganisms at the level of species or genus, which were further classified into five types, including bacteria (72.73%), fungi (13.29%), virus (11.89%), mycoplasma (1.4%), and parasites (0.7%) (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). When analyzed at the species level, <italic>S. pneumoniae</italic> (28.95%) and <italic>H. parainfluenzae</italic> (23.68%) were the top two bacteria, followed by <italic>S. aureus</italic> (21.05%), <italic>S. pseudopneumoniae</italic> (21.05%), <italic>K. pneumoniae</italic> (21.05%), and <italic>A. baumannii complex</italic> (21.05%) (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>). <italic>C. albicans</italic> (21.05%) was the most dominant fungi detected with mNGS. <italic>Human betaherpesvirus 5</italic> (18.42%) was the most prevalent virus. Seven pathogenic microorganisms were detected through the traditional culture method in 10 airway secretions samples. <italic>K. pneumoniae</italic> was detected in three cases (7.89%); <italic>S. aureus</italic> was detected in two samples (5.26%) (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>). The other bacteria include <italic>A. baumannii</italic> and <italic>A. ursingii</italic>, and fungi like <italic>C. parapsilosis</italic> were detected in one sample (2.63%).</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>The number of pathogenic microorganisms detected by mNGS and microbial culture in the airway secretions samples collected within two hours from lung transplant recipients.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" rowspan="2" align="center">Samples</th>
<th valign="top" colspan="3" align="center">mNGS</th>
<th valign="top" colspan="2" align="center">Microbial culture</th>
<th valign="top" rowspan="2" align="center">Infection status of patients</th>
</tr>
<tr>
<th valign="top" align="center">Bacteria</th>
<th valign="top" align="center">Fungi</th>
<th valign="top" align="center">Viruses</th>
<th valign="top" align="center">Bacteria</th>
<th valign="top" align="center">Fungi</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">S1</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Infected</td>
</tr>
<tr>
<td valign="top" align="left">S2</td>
<td valign="top" align="center">13</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Infected</td>
</tr>
<tr>
<td valign="top" align="left">S3</td>
<td valign="top" align="center">25</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Infected</td>
</tr>
<tr>
<td valign="top" align="left">S4</td>
<td valign="top" align="center">21</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Infected</td>
</tr>
<tr>
<td valign="top" align="left">S5</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Infected</td>
</tr>
<tr>
<td valign="top" align="left">S6</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Infected</td>
</tr>
<tr>
<td valign="top" align="left">S7</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Infected</td>
</tr>
<tr>
<td valign="top" align="left">S8</td>
<td valign="top" align="center">13</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Infected</td>
</tr>
<tr>
<td valign="top" align="left">S9</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Infected</td>
</tr>
<tr>
<td valign="top" align="left">S10</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Infected</td>
</tr>
<tr>
<td valign="top" align="left">S11</td>
<td valign="top" align="center">12</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Infected</td>
</tr>
<tr>
<td valign="top" align="left">S12</td>
<td valign="top" align="center">11</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Infected</td>
</tr>
<tr>
<td valign="top" align="left">S13</td>
<td valign="top" align="center">21</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Infected</td>
</tr>
<tr>
<td valign="top" align="left">S14</td>
<td valign="top" align="center">16</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Infected</td>
</tr>
<tr>
<td valign="top" align="left">S15</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Infected</td>
</tr>
<tr>
<td valign="top" align="left">S16</td>
<td valign="top" align="center">29</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">Infected</td>
</tr>
<tr>
<td valign="top" align="left">S17</td>
<td valign="top" align="center">6</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Infected</td>
</tr>
<tr>
<td valign="top" align="left">S18</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Infected</td>
</tr>
<tr>
<td valign="top" align="left">S19</td>
<td valign="top" align="center">22</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Infected</td>
</tr>
<tr>
<td valign="top" align="left">S20</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Infected</td>
</tr>
<tr>
<td valign="top" align="left">S21</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Infected</td>
</tr>
<tr>
<td valign="top" align="left">S22</td>
<td valign="top" align="center">22</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Infected</td>
</tr>
<tr>
<td valign="top" align="left">S23</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Infected</td>
</tr>
<tr>
<td valign="top" align="left">S24</td>
<td valign="top" align="center">18</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Infected</td>
</tr>
<tr>
<td valign="top" align="left">S25</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Infected</td>
</tr>
<tr>
<td valign="top" align="left">S26</td>
<td valign="top" align="center">5</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Infected</td>
</tr>
<tr>
<td valign="top" align="left">S27</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Uninfected</td>
</tr>
<tr>
<td valign="top" align="left">S28</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Uninfected</td>
</tr>
<tr>
<td valign="top" align="left">S29</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Uninfected</td>
</tr>
<tr>
<td valign="top" align="left">S30</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">Uninfected</td>
</tr>
<tr>
<td valign="top" align="left">S31</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Uninfected</td>
</tr>
<tr>
<td valign="top" align="left">S32</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Uninfected</td>
</tr>
<tr>
<td valign="top" align="left">S33</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Uninfected</td>
</tr>
<tr>
<td valign="top" align="left">S34</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Uninfected</td>
</tr>
<tr>
<td valign="top" align="left">S35</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Uninfected</td>
</tr>
<tr>
<td valign="top" align="left">S36</td>
<td valign="top" align="center">16</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Uninfected</td>
</tr>
<tr>
<td valign="top" align="left">S37</td>
<td valign="top" align="center">31</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Uninfected</td>
</tr>
<tr>
<td valign="top" align="left">S38</td>
<td valign="top" align="center">16</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">Uninfected</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Pathogen spectrum detected by mNGS and traditional culture in airway secretions collected within two hours following lung transplant. <bold>(A)</bold> Classification of pathogenic microorganisms detected by mNGS; <bold>(B)</bold> Pathogenic spectrum detected by mNGS; <bold>(C)</bold> Pathogenic spectrum detected by conventional microbial culture.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1271919-g002.tif"/>
</fig>
</sec>
<sec id="s3_3">
<title>Time distribution of infection within one month after transplant and the consistency between mNGS-reported pathogens and the causative agents</title>
<p>
<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref> illustrates the results of etiological identification by mNGS and traditional culture and the information on causative agents in recipients infected within one month. Within one month, 26 (68.42%) of the 38 recipients got infected, and the median time of new-onset infection was 9 days, ranging from 3 to 25 days. Among the 26 infected recipients, 10 (38.46%) got infected within one week following the lung transplant operation, and infection in 7 (26.92%) cases occurred within one to two weeks. The remaining 7 (26.92%) and 2 (7.69%) got infected within two to three weeks and three to four weeks, respectively (<xref ref-type="table" rid="T3">
<bold>Table&#xa0;3</bold>
</xref>). Consequently, infection onset within one week was the highest, and more than half (65.38%) of recipients developed an infection within two weeks. The drug sensitivity of the pathogens was also examined through microbial culture and demonstrated in <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>. Multiple drug resistance was observed in <italic>S. aureus</italic> (case 1), <italic>A. baumannii</italic> (case 8)<italic>, S. maltophilia</italic> (case 11), and <italic>B. multivorans</italic> (case 15).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>The information of two hours airway secretions mNGS and microbial culture results and the causative agents in recipients infected within one month. The gridlines stand for different pathogenic microorganism when comparing the results of mNGS and microbial culture with the causative agents.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1271919-g003.tif"/>
</fig>
<table-wrap id="T3" position="float">
<label>Table&#xa0;3</label>
<caption>
<p>The time distribution of infection within one month in lung recipients.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="center">Onset time of infection</th>
<th valign="top" align="center">Number of infected cases</th>
<th valign="top" align="left">Proportions in the infected patients</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="center">Within one week</td>
<td valign="top" align="center">10</td>
<td valign="top" align="center">38.46%</td>
</tr>
<tr>
<td valign="top" align="center">One-two weeks</td>
<td valign="top" align="center">7</td>
<td valign="top" align="center">26.92%</td>
</tr>
<tr>
<td valign="top" align="center">Two-three weeks</td>
<td valign="top" align="center">7</td>
<td valign="top" align="center">26.92%</td>
</tr>
<tr>
<td valign="top" align="center">Three-four weeks</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">7.69%</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The consistency of two hours airway secretions-mNGS and microbial culture results with the causative agents in the infected recipients was determined at the species level and illustrated in <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>. In 9 (34.62%, 9/26) infected recipients (patient 1, 2, 3, 5, 7, 8, 12, 13, 26), their causative agents were detected by mNGS in advance (in the airway secretions collected within two hours), who got an infection at the 3rd, 3rd, 3rd, 5th, 5th, 5th, 8th, 8th, and 25th day, respectively, after lung transplant (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>). Except for an infection caused by <italic>A. fumigatus</italic> on the 25th day, the median time of infection occurring in the rest 8 recipients was 5 days following the operation. Namely, most of them (6, 66.67%) were infected within one week, 2 (22.22%) cases suffered between one to two weeks, and 1 (11.11%) at three to four weeks (<xref ref-type="table" rid="T4">
<bold>Table&#xa0;4</bold>
</xref>). A decreased trend was observed in consistency, along with the prolonged infection time.</p>
<table-wrap id="T4" position="float">
<label>Table&#xa0;4</label>
<caption>
<p>The consistency of mNGS results in two hours of airway secretions with the causative agents in infected recipients.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Onset time of infection</th>
<th valign="top" align="left">Number of cases in which mNGS was consistent with the causative agents</th>
<th valign="top" align="left">Proportions</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Within one week</td>
<td valign="top" align="center">6</td>
<td valign="top" align="center">66.67%</td>
</tr>
<tr>
<td valign="top" align="left">One-two weeks</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">22.22%</td>
</tr>
<tr>
<td valign="top" align="left">Two-three weeks</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0%</td>
</tr>
<tr>
<td valign="top" align="left">Three-four weeks</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">11.11%</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>Our study retrospectively investigated the ultra-early and early etiological characteristic in lung transplant recipients, whose results may provide reference for early antimicrobial strategy in lung transplant recipients. This study completed pathogen identification through the mNGS technology and microbial culture. In general, mNGS performed well in finding diverse microbial species and might serve as an effective supplementary means to traditional etiological detection methods.</p>
<p>In various infectious diseases, the diagnostic accuracy of mNGS is frequently compared with that of conventional detection methods (<xref ref-type="bibr" rid="B28">28</xref>). In this study, the traditional culture method served as the control group versus mNGS, whose positive rate for pathogen identification was shallow compared to that of mNGS (26.31% vs. 92.11%). Ju et&#xa0;al. also observed a significantly higher positive rate of mNGS than conventional detection methods (83.4% vs. 55.8%) in airway secretions specimens, with a higher diversity of pathogens simultaneously (<xref ref-type="bibr" rid="B17">17</xref>). In our 38 airway secretions samples, mNGS identified 143 kinds of microorganism, ranging from bacteria (72.73%), fungi (13.29%), virus (11.89%), mycoplasma (1.4%), to parasites (0.7%) (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). The pathogen spectrum revealed that mNGS reported more total amount of pathogen than microbial culture (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2B, C</bold>
</xref>). Moreover, mNGS showed absolute superiority in the detection of virus and parasite. Viral infection after lung transplant is common and classified into diseases caused by cytomegalovirus or by other community-acquired respiratory viruses (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B29">29</xref>). It has been reported that viral pathogens are involved in 25 of 71 infectious episodes in a cohort of lung transplant recipients, with cytomegalovirus-related diseases accounting for 68% of them (<xref ref-type="bibr" rid="B8">8</xref>). Without doubt, the conventional diagnosis of parasitic infections in lung transplant recipients is complicated, with clinical suspicion combined with molecular diagnostic methods such as PCR (<xref ref-type="bibr" rid="B30">30</xref>). Therefore, the application of mNGS benefits the etiological diagnosis of rare pathogens. To sum up, we claimed that mNGS is superior to the conventional culture in detection rate and in finding more pathogenic microorganisms with a higher diversity, contributing to a wider reference of pathogen screening and the later prophylactic treatment.</p>
<p>Bacterial infections are the most frequent infectious complications. In a Swiss transplant cohort study, 55% of all lung transplant recipients developed infections in the first year, and 63% were bacterial (<xref ref-type="bibr" rid="B31">31</xref>). More than half of the pathogens detected in the current study were bacterial microbes, and <italic>S. pneumoniae</italic> (28.95%) and <italic>H. parainfluenzae</italic> (23.68%) were the top two bacteria, followed by <italic>S. aureus</italic> (21.05%), <italic>S. pseudopneumoniae</italic> (21.05%), <italic>K. pneumoniae</italic> (21.05%), and <italic>A. baumannii complex</italic> (21.05%) (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>). They are all the common opportunistic pathogen invading the respiratory tract, and are more likely to invoking infection following lung transplant under immunosuppression (<xref ref-type="bibr" rid="B32">32</xref>&#x2013;<xref ref-type="bibr" rid="B34">34</xref>). Thereinto, <italic>S. pneumoniae</italic> and <italic>H. influenzae</italic> are among the main vaccine-preventable bacterial infections in immunocompromised individuals like recipients of solid organ transplants, resulting in a large proportion of hospitalization (<xref ref-type="bibr" rid="B34">34</xref>). It has been proven that <italic>K. pneumoniae</italic> is commonly isolated after lung transplantation, and carbapenem-resistant <italic>K. pneumoniae</italic> acquisition is associated with an increased risk of bronchial dehiscence and reduced survival among recipients (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B35">35</xref>). As reported, fungi are frequently isolated before and after transplantation from respiratory samples, and fungal infections are more common in lung transplant recipients than in most other solid organs (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B36">36</xref>, <xref ref-type="bibr" rid="B37">37</xref>). In the fungi detected in our samples, <italic>Candida</italic> (34.21%) was the most frequently detected, with <italic>C. albicans</italic> (21.05%) as the predominant species. It led to one infection event in case 11 at 8th day after the operation. <italic>Candida</italic> leads to most fungal extrapulmonary infections in lung transplant recipients, and frequently occurs one-month after the transplant (<xref ref-type="bibr" rid="B38">38</xref>). It has been reported that the average period of <italic>Aspergillus</italic>-related infection is 42 days after lung transplantation (<xref ref-type="bibr" rid="B12">12</xref>). Our data demonstrated that recipients 9, 15, and 26 were infected by <italic>Aspergillus</italic> on the 6th, 12th, and 25th days after transplant, respectively. In the pathogenic microorganisms identified by mNGS, bacterial pathogens account for more than half (72.73%), with gram-positive and -negative bacteria occupying large proportions. Fungi such as <italic>Candida</italic> are also frequently detected. Therefore, the initial empirical anti-infection regimes covering the bacteria and fungi are reasonable, and the broad spectrum antimicrobial drugs can be substituted by the narrows after the mNGS results produced.</p>
<p>Within one month, 68.42% (26/38) of recipients got infected, and more than half of the infections happened within two weeks. According to <xref ref-type="table" rid="T4">
<bold>Table&#xa0;4</bold>
</xref>, mNGS could predict the causative agents in early infection, especially for the infection onset within one week. Notoriously, donor-derived infections generally manifest during the first few weeks after lung transplant (<xref ref-type="bibr" rid="B31">31</xref>). Many deceased donors were more likely to carry pathogens with multiple drug resistance (MDR) or suffered from hospital infections because they stay in the intensive care unit (<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B40">40</xref>). Our <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref> indicated that MDR bacteria were detected in airway secretions samples from 4 cases, and they were <italic>S. aureus</italic> (case 1), <italic>A. baumannii</italic> (case 8), <italic>S. maltophilia</italic> (case 11), and <italic>B. multivorans</italic> (case 15). Bunsow reported that MDR bacteria were isolated from 4.9% (12/243) of donors, including <italic>Enterobacterales</italic>, <italic>S. maltophilia</italic>, <italic>P. aeruginosa</italic>, and <italic>S. aureus </italic>(<xref ref-type="bibr" rid="B41">41</xref>). These MDR bacteria should be highly suspected in the cases of infection occurred within 48h or infection worsened after transplant.</p>
<p>In the present studies concerning post-operative infection after lung transplant, many researchers focus on a longer duration, such as three months, one year, even five years (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B42">42</xref>&#x2013;<xref ref-type="bibr" rid="B44">44</xref>), but early infection within one month has rarely been highlighted. Our study revealed that the median time of new-onset infection was nine days, 38.46% of recipients got infected within one week, and even 65.38% developed infection within two weeks. The high incidence of infection in lung transplant recipients may be associated with the destruction of the mucosal barrier, which was improved with the repair of the mucous membrane (<xref ref-type="bibr" rid="B45">45</xref>). Therefore, it is essential to repair the mucosal barrier by removing the tracheal catheters as soon as possible (<xref ref-type="bibr" rid="B46">46</xref>). In the infections that occurred shortly after the transplant, the consistency between mNGS results and the etiological agents was high but decreased with the prolonged time interval. That is, the predictive role of mNGS in etiological agents is time-limited, suggesting that continuous pathogenic screening is indispensable for infection prevention (<xref ref-type="bibr" rid="B47">47</xref>). With the deepening of research on pathogenic microorganisms affecting lung transplant recipients and advances in pathogen detection technologies, the infection risks are expected to be perceived earlier and specifically intervened to prevent infection and improve their survival rate.</p>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: PRJNA932550 (SRA).</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The studies involving humans were approved by Medical Ethics Committee of Sichuan Provincial People&#x2019;s Hospital (No. 2021-399). The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>XZ: Conceptualization, Data curation, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. XT: Data curation, Formal Analysis, Investigation, Visualization, Writing &#x2013; original draft. XY: Data curation, Software, Writing &#x2013; review &amp; editing. YL: Data curation, Methodology, Writing &#x2013; review &amp; editing. SL: Data curation, Methodology, Writing &#x2013; review &amp; editing. TL: Data curation, Methodology, Writing &#x2013; review &amp; editing. RY: Investigation, Methodology, Writing &#x2013; review &amp; editing. LP: Investigation, Methodology, Writing &#x2013; review &amp; editing. GF: Project administration, Software, Supervision, Visualization, Writing &#x2013; review &amp; editing. XH: Project administration, Software, Supervision, Visualization, Writing &#x2013; review &amp; editing. YW: Conceptualization, Formal Analysis, Methodology, Writing &#x2013; review &amp; editing. DC: Conceptualization, Formal Analysis, Methodology, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing.</p>
</sec>
</body>
<back>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>The authors declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by grants from the Health Commission of Sichuan Province (No. 21PJ080) and the Wu Jieping Medical Foundation (No. 2022HX019).</p>
</sec>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>Author XY was employed by the company Genoxor Medical Science and Technology Inc.</p>
<p>The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2023.1271919/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fimmu.2023.1271919/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet_1.xlsx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ivulich</surname> <given-names>S</given-names>
</name>
<name>
<surname>Westall</surname> <given-names>G</given-names>
</name>
<name>
<surname>Dooley</surname> <given-names>M</given-names>
</name>
<name>
<surname>Snell</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>The evolution of lung transplant immunosuppression</article-title>. <source>Drugs</source> (<year>2018</year>) <volume>78</volume>(<issue>10</issue>):<page-range>965&#x2013;82</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s40265-018-0930-6</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Young</surname> <given-names>KA</given-names>
</name>
<name>
<surname>Dilling</surname> <given-names>DF</given-names>
</name>
</person-group>. <article-title>The future of lung transplantation</article-title>. <source>Chest</source> (<year>2019</year>) <volume>155</volume>(<issue>3</issue>):<page-range>465&#x2013;73</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.chest.2018.08.1036</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lehr</surname> <given-names>CJ</given-names>
</name>
<name>
<surname>Blackstone</surname> <given-names>EH</given-names>
</name>
<name>
<surname>McCurry</surname> <given-names>KR</given-names>
</name>
<name>
<surname>Thuita</surname> <given-names>L</given-names>
</name>
<name>
<surname>Tsuang</surname> <given-names>WM</given-names>
</name>
<name>
<surname>Valapour</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Extremes of age decrease survival in adults after lung transplant</article-title>. <source>Chest</source> (<year>2020</year>) <volume>157</volume>(<issue>4</issue>):<page-range>907&#x2013;15</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.chest.2019.06.042</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burguete</surname> <given-names>SR</given-names>
</name>
<name>
<surname>Maselli</surname> <given-names>DJ</given-names>
</name>
<name>
<surname>Fernandez</surname> <given-names>JF</given-names>
</name>
<name>
<surname>Levine</surname> <given-names>SM</given-names>
</name>
</person-group>. <article-title>Lung transplant infection</article-title>. <source>Respirology</source> (<year>2013</year>) <volume>18</volume>(<issue>1</issue>):<fpage>22</fpage>&#x2013;<lpage>38</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1440-1843.2012.02196.x</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grewal</surname> <given-names>HS</given-names>
</name>
<name>
<surname>Highland</surname> <given-names>KB</given-names>
</name>
<name>
<surname>McCurry</surname> <given-names>K</given-names>
</name>
<name>
<surname>Akindipe</surname> <given-names>O</given-names>
</name>
<name>
<surname>Budev</surname> <given-names>M</given-names>
</name>
<name>
<surname>Mehta</surname> <given-names>AC</given-names>
</name>
</person-group>. <article-title>Bacterial meningitis as a cause of death in lung transplant donors: early outcomes in recipients</article-title>. <source>Clin Transplant</source> (<year>2018</year>) <volume>32</volume>(<issue>8</issue>):<elocation-id>e13307</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/ctr.13307</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Costa</surname> <given-names>J</given-names>
</name>
<name>
<surname>Benvenuto</surname> <given-names>LJ</given-names>
</name>
<name>
<surname>Sonett</surname> <given-names>JR</given-names>
</name>
</person-group>. <article-title>Long-term outcomes and management of lung transplant recipients</article-title>. <source>Best Pract Res Clin Anaesthesiol</source> (<year>2017</year>) <volume>31</volume>(<issue>2</issue>):<page-range>285&#x2013;97</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bpa.2017.05.006</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname> <given-names>CX</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>WH</given-names>
</name>
<name>
<surname>He</surname> <given-names>JX</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>GN</given-names>
</name>
<name>
<surname>Li</surname> <given-names>XS</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Lung transplantation in China between 2015 and 2018</article-title>. <source>Chin Med J (Engl)</source> (<year>2019</year>) <volume>132</volume>(<issue>23</issue>):<page-range>2783&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/CM9.0000000000000543</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parada</surname> <given-names>MT</given-names>
</name>
<name>
<surname>Alba</surname> <given-names>A</given-names>
</name>
<name>
<surname>Sepulveda</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Early and late infections in lung transplantation patients</article-title>. <source>Transplant Proc</source> (<year>2010</year>) <volume>42</volume>(<issue>1</issue>):<page-range>333&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.transproceed.2009.12.002</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>E</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>M</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Metagenomic next-generation sequencing versus traditional pathogen detection in the diagnosis of peripheral pulmonary infectious lesions</article-title>. <source>Infect Drug Resist</source> (<year>2020</year>) <volume>13</volume>:<page-range>567&#x2013;76</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2147/IDR.S235182</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stjarne Aspelund</surname> <given-names>A</given-names>
</name>
<name>
<surname>Hammarstrom</surname> <given-names>H</given-names>
</name>
<name>
<surname>Inghammar</surname> <given-names>M</given-names>
</name>
<name>
<surname>Larsson</surname> <given-names>H</given-names>
</name>
<name>
<surname>Hansson</surname> <given-names>L</given-names>
</name>
<name>
<surname>Christensson</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Heparin-binding protein, lysozyme, and inflammatory cytokines in bronchoalveolar lavage fluid as diagnostic tools for pulmonary infection in lung transplanted patients</article-title>. <source>Am J Transplant</source> (<year>2018</year>) <volume>18</volume>(<issue>2</issue>):<page-range>444&#x2013;52</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/ajt.14458</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qiao</surname> <given-names>W</given-names>
</name>
<name>
<surname>Zou</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ping</surname> <given-names>F</given-names>
</name>
<name>
<surname>Han</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Li</surname> <given-names>L</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>Fungal infection in lung transplant recipients in perioperative period from one lung transplant center</article-title>. <source>J Thorac Dis</source> (<year>2019</year>) <volume>11</volume>(<issue>4</issue>):<page-range>1554&#x2013;61</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.21037/jtd.2019.03.18</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kennedy</surname> <given-names>CC</given-names>
</name>
<name>
<surname>Pennington</surname> <given-names>KM</given-names>
</name>
<name>
<surname>Beam</surname> <given-names>E</given-names>
</name>
<name>
<surname>Razonable</surname> <given-names>RR</given-names>
</name>
</person-group>. <article-title>Fungal infection in lung transplantation</article-title>. <source>Semin Respir Crit Care Med</source> (<year>2021</year>) <volume>42</volume>(<issue>3</issue>):<page-range>471&#x2013;82</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1055/s-0041-1729173</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jacobs</surname> <given-names>F</given-names>
</name>
<name>
<surname>Knoop</surname> <given-names>C</given-names>
</name>
<name>
<surname>Brancart</surname> <given-names>F</given-names>
</name>
<name>
<surname>Gilot</surname> <given-names>P</given-names>
</name>
<name>
<surname>Melot</surname> <given-names>C</given-names>
</name>
<name>
<surname>Byl</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Human herpesvirus-6 infection after lung and heart-lung transplantation: a prospective longitudinal study</article-title>. <source>Transplantation</source> (<year>2003</year>) <volume>75</volume>(<issue>12</issue>):<fpage>1996</fpage>&#x2013;<lpage>2001</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/01.TP.0000058809.42027.66</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname> <given-names>D</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Li</surname> <given-names>R</given-names>
</name>
<name>
<surname>Tan</surname> <given-names>P</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>R</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>mNGS in clinical microbiology laboratories: on the road to maturity</article-title>. <source>Crit Rev Microbiol</source> (<year>2019</year>) <volume>45</volume>(<issue>5-6</issue>):<page-range>668&#x2013;85</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/1040841X.2019.1681933</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>D</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>L</given-names>
</name>
<name>
<surname>Lian</surname> <given-names>D</given-names>
</name>
<name>
<surname>Gu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>X</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Diagnostic value and clinical application of mNGS for post-liver transplantation infection: A cross-sectional study with case reports</article-title>. <source>Front Microbiol</source> (<year>2022</year>) <volume>13</volume>:<elocation-id>919363</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2022.919363</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duan</surname> <given-names>W</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>J</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>T</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>Application of metagenomic next-generation sequencing in the diagnosis and treatment of recurrent urinary tract infection in kidney transplant recipients</article-title>. <source>Front Public Health</source> (<year>2022</year>) <volume>10</volume>:<elocation-id>901549</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fpubh.2022.901549</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ju</surname> <given-names>CR</given-names>
</name>
<name>
<surname>Lian</surname> <given-names>QY</given-names>
</name>
<name>
<surname>Guan</surname> <given-names>WJ</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>A</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Metagenomic next-generation sequencing for diagnosing infections in lung transplant recipients: a retrospective study</article-title>. <source>Transpl Int</source> (<year>2022</year>) <volume>35</volume>:<elocation-id>10265</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/ti.2022.10265</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>XQ</given-names>
</name>
<name>
<surname>Lei</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Tan</surname> <given-names>XL</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>L</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>XB</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>FX</given-names>
</name>
<etal/>
</person-group>. <article-title>Optimization of early antimicrobial strategies for lung transplant recipients based on metagenomic next-generation sequencing</article-title>. <source>Front Microbiol</source> (<year>2022</year>) <volume>13</volume>:<elocation-id>839698</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2022.839698</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pan</surname> <given-names>L</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>F</given-names>
</name>
<name>
<surname>Cai</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Whole genome profiling of lung microbiome in solid organ transplant recipients reveals virus involved microecology may worsen prognosis</article-title>. <source>Front Cell Infect Microbiol</source> (<year>2022</year>) <volume>12</volume>:<elocation-id>863399</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2022.863399</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>L</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Qin</surname> <given-names>K</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Metagenomic assessment of the pathogenic risk of microorganisms in sputum of post-operative patients with pulmonary infection</article-title>. <source>Front Cell Infect Microbiol</source> (<year>2022</year>) <volume>12</volume>:<elocation-id>855839</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2022.855839</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bolger</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Lohse</surname> <given-names>M</given-names>
</name>
<name>
<surname>Usadel</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Trimmomatic: a flexible trimmer for Illumina sequence data</article-title>. <source>Bioinformatics</source> (<year>2014</year>) <volume>30</volume>(<issue>15</issue>):<page-range>2114&#x2013;20</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/bioinformatics/btu170</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Langmead</surname> <given-names>B</given-names>
</name>
<name>
<surname>Salzberg</surname> <given-names>SL</given-names>
</name>
</person-group>. <article-title>Fast gapped-read alignment with Bowtie 2</article-title>. <source>Nat Methods</source> (<year>2012</year>) <volume>9</volume>(<issue>4</issue>):<page-range>357&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nmeth.1923</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname> <given-names>TC</given-names>
</name>
<name>
<surname>Visconti</surname> <given-names>A</given-names>
</name>
<name>
<surname>Spector</surname> <given-names>TD</given-names>
</name>
<name>
<surname>Falchi</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Conducting metagenomic studies in microbiology and clinical research</article-title>. <source>Appl Microbiol Biotechnol</source> (<year>2018</year>) <volume>102</volume>(<issue>20</issue>):<page-range>8629&#x2013;46</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00253-018-9209-9</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wood</surname> <given-names>DE</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Langmead</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Improved metagenomic analysis with Kraken 2</article-title>. <source>Genome Biol</source> (<year>2019</year>) <volume>20</volume>(<issue>1</issue>):<fpage>257</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13059-019-1891-0</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kitts</surname> <given-names>PA</given-names>
</name>
<name>
<surname>Church</surname> <given-names>DM</given-names>
</name>
<name>
<surname>Thibaud-Nissen</surname> <given-names>F</given-names>
</name>
<name>
<surname>Choi</surname> <given-names>J</given-names>
</name>
<name>
<surname>Hem</surname> <given-names>V</given-names>
</name>
<name>
<surname>Sapojnikov</surname> <given-names>V</given-names>
</name>
<etal/>
</person-group>. <article-title>Assembly: a resource for assembled genomes at NCBI</article-title>. <source>Nucleic Acids Res</source> (<year>2016</year>) <volume>44</volume>(<issue>D1</issue>):<page-range>D73&#x2013;80</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkv1226</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Breitwieser</surname> <given-names>FP</given-names>
</name>
<name>
<surname>Thielen</surname> <given-names>P</given-names>
</name>
<name>
<surname>Salzberg</surname> <given-names>SL</given-names>
</name>
</person-group>. <article-title>Bracken: estimating species abundance in metagenomics data</article-title>. <source>Peerj Comput Sci</source> (<year>2017</year>) <volume>3</volume>(<issue>1</issue>):<elocation-id>e104</elocation-id>. doi: <pub-id pub-id-type="doi">10.7717/peerj-cs.104</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>C</given-names>
</name>
<name>
<surname>You</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Fu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>S</given-names>
</name>
<name>
<surname>Bai</surname> <given-names>D</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Application of metagenomic next-generation sequencing in the diagnosis of pulmonary invasive fungal disease</article-title>. <source>Front Cell Infect Microbiol</source> (<year>2022</year>) <volume>12</volume>:<elocation-id>949505</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2022.949505</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Shang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>G</given-names>
</name>
<name>
<surname>Bai</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>The clinical significance of simultaneous detection of pathogens from bronchoalveolar lavage fluid and blood samples by metagenomic next-generation sequencing in patients with severe pneumonia</article-title>. <source>J Med Microbiol</source> (<year>2021</year>) <volume>70</volume>(<issue>1</issue>):<fpage>001259</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1099/jmm.0.001259</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Almaghrabi</surname> <given-names>RS</given-names>
</name>
<name>
<surname>Omrani</surname> <given-names>AS</given-names>
</name>
<name>
<surname>Memish</surname> <given-names>ZA</given-names>
</name>
</person-group>. <article-title>Cytomegalovirus infection in lung transplant recipients</article-title>. <source>Expert Rev Respir Med</source> (<year>2017</year>) <volume>11</volume>(<issue>5</issue>):<page-range>377&#x2013;83</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/17476348.2017.1317596</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van den Bogaart</surname> <given-names>L</given-names>
</name>
<name>
<surname>Cipriano</surname> <given-names>A</given-names>
</name>
<name>
<surname>Koutsokera</surname> <given-names>A</given-names>
</name>
<name>
<surname>Manuel</surname> <given-names>O</given-names>
</name>
</person-group>. <article-title>Understanding rare infections post-lung transplantation</article-title>. <source>Expert Rev Respir Med</source> (<year>2021</year>) <volume>15</volume>(<issue>3</issue>):<page-range>325&#x2013;38</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/17476348.2021.1843428</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCort</surname> <given-names>M</given-names>
</name>
<name>
<surname>MacKenzie</surname> <given-names>E</given-names>
</name>
<name>
<surname>Pursell</surname> <given-names>K</given-names>
</name>
<name>
<surname>Pitrak</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Bacterial infections in lung transplantation</article-title>. <source>J Thorac Dis</source> (<year>2021</year>) <volume>13</volume>(<issue>11</issue>):<page-range>6654&#x2013;72</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.21037/jtd-2021-12</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oh</surname> <given-names>DH</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>YC</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>EJ</given-names>
</name>
<name>
<surname>Jung</surname> <given-names>IY</given-names>
</name>
<name>
<surname>Jeong</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>SY</given-names>
</name>
<etal/>
</person-group>. <article-title>Multidrug-resistant Acinetobacter baumannii infection in lung transplant recipients: risk factors and prognosis</article-title>. <source>Infect Dis (Lond)</source> (<year>2019</year>) <volume>51</volume>(<issue>7</issue>):<fpage>493</fpage>&#x2013;<lpage>501</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/23744235.2018.1556400</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suh</surname> <given-names>JW</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>JG</given-names>
</name>
<name>
<surname>Jeong</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Park</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>SY</given-names>
</name>
<name>
<surname>Paik</surname> <given-names>HC</given-names>
</name>
</person-group>. <article-title>Risk of bronchial dehiscence in lung transplant recipients with Carbapenemase-producing Klebsiella</article-title>. <source>Ann Thorac Surg</source> (<year>2020</year>) <volume>110</volume>(<issue>1</issue>):<page-range>265&#x2013;71</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.athoracsur.2020.01.076</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rezahosseini</surname> <given-names>O</given-names>
</name>
<name>
<surname>Moller</surname> <given-names>DL</given-names>
</name>
<name>
<surname>Sorensen</surname> <given-names>SS</given-names>
</name>
<name>
<surname>Perch</surname> <given-names>M</given-names>
</name>
<name>
<surname>Gustafsson</surname> <given-names>F</given-names>
</name>
<name>
<surname>Gelpi</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>An observational prospective cohort study of incidence and outcome of streptococcus pneumoniae and hemophilus influenzae infections in adult solid organ transplant recipients</article-title>. <source>Microorganisms</source> (<year>2021</year>) <volume>9</volume>(<issue>7</issue>):<fpage>1371</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/microorganisms9071371</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raviv</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Shitrit</surname> <given-names>D</given-names>
</name>
<name>
<surname>Amital</surname> <given-names>A</given-names>
</name>
<name>
<surname>Fox</surname> <given-names>B</given-names>
</name>
<name>
<surname>Bakal</surname> <given-names>I</given-names>
</name>
<name>
<surname>Tauber</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Multidrug-resistant Klebsiella pneumoniae acquisition in lung transplant recipients</article-title>. <source>Clin Transplant</source> (<year>2012</year>) <volume>26</volume>(<issue>4</issue>):<page-range>E388&#x2013;394</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1399-0012.2012.01671.x</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pappas</surname> <given-names>PG</given-names>
</name>
<name>
<surname>Alexander</surname> <given-names>BD</given-names>
</name>
<name>
<surname>Andes</surname> <given-names>DR</given-names>
</name>
<name>
<surname>Hadley</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kauffman</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Freifeld</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)</article-title>. <source>Clin Infect Dis</source> (<year>2010</year>) <volume>50</volume>(<issue>8</issue>):<page-range>1101&#x2013;11</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1086/651262</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adegunsoye</surname> <given-names>A</given-names>
</name>
<name>
<surname>Strek</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Garrity</surname> <given-names>E</given-names>
</name>
<name>
<surname>Guzy</surname> <given-names>R</given-names>
</name>
<name>
<surname>Bag</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Comprehensive care of the lung transplant patient</article-title>. <source>Chest</source> (<year>2017</year>) <volume>152</volume>(<issue>1</issue>):<page-range>150&#x2013;64</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.chest.2016.10.001</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Villalobos</surname> <given-names>AP</given-names>
</name>
<name>
<surname>Husain</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Infection prophylaxis and management of fungal infections in lung transplant</article-title>. <source>Ann Transl Med</source> (<year>2020</year>) <volume>8</volume>(<issue>6</issue>):<fpage>414</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.21037/atm.2020.03.102</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>KH</given-names>
</name>
<name>
<surname>Jeong</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>SY</given-names>
</name>
<name>
<surname>Han</surname> <given-names>SH</given-names>
</name>
<name>
<surname>Park</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>JG</given-names>
</name>
<etal/>
</person-group>. <article-title>Effects of multidrug-resistant bacteria in donor lower respiratory tract on early posttransplant pneumonia in lung transplant recipients without pretransplant infection</article-title>. <source>Transplantation</source> (<year>2020</year>) <volume>104</volume>(<issue>4</issue>):<fpage>e98</fpage>&#x2013;<lpage>e106</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/TP.0000000000003102</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paglicci</surname> <given-names>L</given-names>
</name>
<name>
<surname>Borgo</surname> <given-names>V</given-names>
</name>
<name>
<surname>Lanzarone</surname> <given-names>N</given-names>
</name>
<name>
<surname>Fabbiani</surname> <given-names>M</given-names>
</name>
<name>
<surname>Cassol</surname> <given-names>C</given-names>
</name>
<name>
<surname>Cusi</surname> <given-names>MG</given-names>
</name>
<etal/>
</person-group>. <article-title>Incidence and risk factors for respiratory tract bacterial colonization and infection in lung transplant recipients</article-title>. <source>Eur J Clin Microbiol Infect Dis</source> (<year>2021</year>) <volume>40</volume>(<issue>6</issue>):<page-range>1271&#x2013;82</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10096-021-04153-1</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bunsow</surname> <given-names>E</given-names>
</name>
<name>
<surname>Los-Arcos</surname> <given-names>I</given-names>
</name>
<name>
<surname>Martin-Gomez</surname> <given-names>MT</given-names>
</name>
<name>
<surname>Bello</surname> <given-names>I</given-names>
</name>
<name>
<surname>Pont</surname> <given-names>T</given-names>
</name>
<name>
<surname>Berastegui</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Donor-derived bacterial infections in lung transplant recipients in the era of multidrug resistance</article-title>. <source>J Infect</source> (<year>2020</year>) <volume>80</volume>(<issue>2</issue>):<page-range>190&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jinf.2019.12.006</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kesten</surname> <given-names>S</given-names>
</name>
<name>
<surname>Chaparro</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Mycobacterial infections in lung transplant recipients</article-title>. <source>Chest</source> (<year>1999</year>) <volume>115</volume>(<issue>3</issue>):<page-range>741&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1378/chest.115.3.741</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moffatt</surname> <given-names>SD</given-names>
</name>
<name>
<surname>Demers</surname> <given-names>P</given-names>
</name>
<name>
<surname>Robbins</surname> <given-names>RC</given-names>
</name>
<name>
<surname>Doyle</surname> <given-names>R</given-names>
</name>
<name>
<surname>Wienacker</surname> <given-names>A</given-names>
</name>
<name>
<surname>Henig</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>Lung transplantation: a decade of experience</article-title>. <source>J Heart Lung Transplant</source> (<year>2005</year>) <volume>24</volume>(<issue>2</issue>):<page-range>145&#x2013;51</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.healun.2003.10.020</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monforte</surname> <given-names>V</given-names>
</name>
<name>
<surname>Ussetti</surname> <given-names>P</given-names>
</name>
<name>
<surname>Castejon</surname> <given-names>R</given-names>
</name>
<name>
<surname>Sintes</surname> <given-names>H</given-names>
</name>
<name>
<surname>Perez</surname> <given-names>VL</given-names>
</name>
<name>
<surname>Laporta</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Predictive value of immune cell functional assay for non-cytomegalovirus infection in lung transplant recipients: a multicenter prospective observational study</article-title>. <source>Arch Bronconeumol</source> (<year>2021</year>) <volume>57</volume>(<issue>11</issue>):<page-range>690&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.arbr.2020.12.012</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biderman</surname> <given-names>P</given-names>
</name>
<name>
<surname>Bugaevsky</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ben-Zvi</surname> <given-names>H</given-names>
</name>
<name>
<surname>Bishara</surname> <given-names>J</given-names>
</name>
<name>
<surname>Goldberg</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Multidrug-resistant Acinetobacter baumannii infections in lung transplant patients in the cardiothoracic intensive care unit</article-title>. <source>Clin Transplant</source> (<year>2015</year>) <volume>29</volume>(<issue>9</issue>):<page-range>756&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/ctr.12575</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fishman</surname> <given-names>JA</given-names>
</name>
</person-group>. <article-title>Infection in solid-organ transplant recipients</article-title>. <source>N Engl J Med</source> (<year>2007</year>) <volume>357</volume>(<issue>25</issue>):<page-range>2601&#x2013;14</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1056/NEJMra064928</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Henkle</surname> <given-names>E</given-names>
</name>
<name>
<surname>Winthrop</surname> <given-names>KL</given-names>
</name>
</person-group>. <article-title>Nontuberculous mycobacteria infections in immunosuppressed hosts</article-title>. <source>Clin Chest Med</source> (<year>2015</year>) <volume>36</volume>(<issue>1</issue>):<page-range>91&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ccm.2014.11.002</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>